Byron Capital Markets

Byron Capital Markets

May 02, 2011 09:56 ET

Byron Capital Markets Hires Senior Biotech and Healthcare Analyst

TORONTO, ONTARIO--(Marketwire - May 2, 2011) - Byron Capital Markets Ltd. is pleased to introduce Dr. David Martin who joins our firm in the position of Senior Research Analyst responsible for research coverage of the Biotechnology and Healthcare sectors.

Dr. Martin most recently held the position of Senior Equity Analyst with a leading independent IIROC firm where, in 2009, he was ranked #1 by StarMine, a Thomson Reuters company, in the category of "Stock Picker (Healthcare)". In 2010, the Brendan Wood International Survey ranked David as the #2 Analyst (Healthcare) amongst independent investment dealers. Biotechnology and Healthcare will be his continued area of focus at Byron Capital Markets.

David holds a B.Sc.(Genetics) from the University of Western Ontario, an M.Sc.(Biology) from the University of Toronto, a Ph.D. (Biochemistry) from the University of Western Ontario, and an MBA from the Richard Ivey School of Business.

We are very excited about the addition of Dr. David Martin to our team of professionals at Byron Capital Markets, and specifically about his future contributions to our firm's continuing efforts in the Biotechnology and Healthcare sectors.

Contact Information